Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171764 | SCV000050779 | likely benign | Catecholaminergic polymorphic ventricular tachycardia type 1 | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000036777 | SCV000060432 | uncertain significance | not specified | 2014-06-05 | criteria provided, single submitter | clinical testing | The Val2113Met variant in RYR2 has been reported in 1 Caucasian adult with sudde n unexplained death and in 1 Caucasian adult with DCM (Tester 2012, Pugh 2014). This variant has also been identified in 6/8320 European American chromosomes b y the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP r s186906598). Computational prediction tools and conservation analysis do not pr ovide strong support for or against an impact to the protein. In summary, the cl inical significance of the Val2113Met variant is uncertain. |
Gene |
RCV000766718 | SCV000235125 | uncertain significance | not provided | 2018-10-24 | criteria provided, single submitter | clinical testing | The V2113M variant of uncertain significance in the RYR2 gene has been reported in a 36-year-old patient with sudden unexplained death after exertion and in a 50-year-old Caucasian female with a clinical diagnosis of dilated cardiomyopathy (DCM) with premature ventricular contractions (PVCs), tachycardia, and a family history of DCM and sudden cardiac death (Tester et al., 2012; Pugh et al., 2014). While this variant has also been identified in several individuals referred for cardiology testing at GeneDx, segregation data are either absent or limited, and some of these individuals harbored an additional cardiogenetic variant. In addition, V2113M has been observed in 100/126,578 alleles (0.08%) from individuals of European (non-Finnish) ancestry in large population cohorts (Lek et al., 2016). V2113M is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. Lastly, the V2113M variant is not located in one of the three hot-spot regions of the RYR2 gene, where the majority of pathogenic missense variant occur (Medeiros- Domingo et al., 2009). |
Invitae | RCV001084786 | SCV000541655 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620555 | SCV000735828 | likely benign | Cardiovascular phenotype | 2018-04-10 | criteria provided, single submitter | clinical testing | In silico models in agreement (benign);Subpopulation frequency in support of benign classification |
CHEO Genetics Diagnostic Laboratory, |
RCV000769789 | SCV000901214 | uncertain significance | Cardiomyopathy | 2017-07-12 | criteria provided, single submitter | clinical testing | |
Color | RCV000769789 | SCV000904500 | likely benign | Cardiomyopathy | 2020-04-15 | criteria provided, single submitter | clinical testing | |
Illumina Clinical Services Laboratory, |
RCV000171764 | SCV001255546 | likely benign | Catecholaminergic polymorphic ventricular tachycardia type 1 | 2017-09-07 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Clinical Services Laboratory, |
RCV001099125 | SCV001255547 | uncertain significance | Arrhythmogenic right ventricular dysplasia, familial, 2 | 2017-09-07 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |